Literature DB >> 11077453

Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet.

S S Likhodii1, K Musa, A Mendonca, C Dell, W M Burnham, S C Cunnane.   

Abstract

PURPOSE: Fat is the major component of the ketogenic diet (KD), yet no studies have examined whether the type of fat used in the diet can be optimized to provide additional benefits. The purpose of the present experiments was to compare the efficiency of different fats in inducing ketosis and affording seizure resistance.
METHODS: The effects of KDs that incorporate lard, butter, medium-chain triglycerides (MCT), or flaxseed oil or a mixture of the latter three fats were examined in rats fed KD for up to 98 days. The maximal electroshock (MES) or pentylenetetrazole (PTZ) threshold tests were used to assess seizure susceptibility in two separate experiments.
RESULTS: The rank order of induced ketosis was MCT > mixture > or = flaxseed oil > or = lard = butter > or = control. MES failed to reveal anticonvulsant effects, but the PTZ test indicated that up to 50% of rats fed the KD were seizure protected (p < 0.05). The measures of seizure protection, seizure incidence and score, did not correlate, however, with the level of ketosis in the range of 0. 7-5.2 mmol/L for beta-hydroxybutyrate. In the long-term study, flaxseed oil KD maintained stable ketosis throughout 98 days, whereas ketones declined with lard and butter KD to the control level.
CONCLUSIONS: Seizure protection with the versions of the KD did not improve with the higher level of ketosis. The focus of the KD improvement, therefore, is not the achievement of higher ketosis per se but rather designing a diet that provides steady ketosis, exploits advantages of certain fats for neurological development or seizure protection via a nonketogenic mechanism, and is nutritionally balanced.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11077453     DOI: 10.1111/j.1528-1157.2000.tb00115.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  27 in total

Review 1.  Ketone bodies in epilepsy.

Authors:  Melanie A McNally; Adam L Hartman
Journal:  J Neurochem       Date:  2012-02-07       Impact factor: 5.372

2.  Dietary approaches to epilepsy treatment: old and new options on the menu.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

Review 3.  Neuroprotective and disease-modifying effects of the ketogenic diet.

Authors:  Maciej Gasior; Michael A Rogawski; Adam L Hartman
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

4.  Energy balance and hypothalamic effects of a high-protein/low-carbohydrate diet.

Authors:  Kimberly P Kinzig; Sara L Hargrave; Jayson Hyun; Timothy H Moran
Journal:  Physiol Behav       Date:  2007-04-22

5.  Ketogenic diet decreases circulating concentrations of neuroactive steroids of female rats.

Authors:  Madeline E Rhodes; Jayanth Talluri; Jacob P Harney; Cheryl A Frye
Journal:  Epilepsy Behav       Date:  2005-09       Impact factor: 2.937

Review 6.  The ketogenic diet: metabolic influences on brain excitability and epilepsy.

Authors:  Andrew Lutas; Gary Yellen
Journal:  Trends Neurosci       Date:  2012-12-08       Impact factor: 13.837

7.  How does the ketogenic diet work? Four potential mechanisms.

Authors:  Nika N Danial; Adam L Hartman; Carl E Stafstrom; Liu Lin Thio
Journal:  J Child Neurol       Date:  2013-05-13       Impact factor: 1.987

8.  Efficacy of the ketogenic diet in the 6-Hz seizure test.

Authors:  Adam L Hartman; Megan Lyle; Michael A Rogawski; Maciej Gasior
Journal:  Epilepsia       Date:  2007-12-06       Impact factor: 5.864

Review 9.  Ketogenic diets and pain.

Authors:  Susan A Masino; David N Ruskin
Journal:  J Child Neurol       Date:  2013-05-16       Impact factor: 1.987

10.  A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype.

Authors:  Kirk Nylen; Jose Luis Perez Velazquez; Sergei S Likhodii; Miguel A Cortez; Lily Shen; Yevgen Leshchenko; Khosrow Adeli; K Michael Gibson; W M Burnham; O Carter Snead
Journal:  Exp Neurol       Date:  2007-11-29       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.